Campaign with special offers on in-clinic screenings and community screenings in residential localities to be conducted in Mumbai first, followed by Pune
Healthspring and Niramai Health Analytix will offer their screening solution Thermalytix for early detection of breast cancer. With the aim to increase awareness on the subject, this association will enable women to understand the importance of timely examination. This screening will be available at Healthspring’s primary care clinics in Mumbai and Pune for individuals and corporates.
The collaboration with Healthspring will involve a promotion that has special offers on in-clinic screenings and community screenings in residential localities. The campaign will be conducted in Mumbai first.
Niramai’s proprietary solution ‘Thermalytix’ uses a high-resolution thermal sensing device and a cloud-hosted analytics solution for analysing thermal images using artificial intelligence and machine learning for reliable, early and accurate breast cancer screening. Recently Niramai launched a solution for screening COVID-19 symptoms using similar thermal-based technology. This screening tool that can be operated by a simple clinician has led to 10 US granted patents and won several prestigious awards.
Commenting that cancer amongst women over 40 years of age is a common phenomenon Dr Gautam Sen, Chairman and Founder of Healthspring, said hoped that through this association, Healthspring looked forward to encouraging as many patients as possible to undertake timely examinations and suitable medical attention.
Dr Geetha Manjunath, Founder & CEO, Niramai said, “Breast cancer is a condition that affects far too many women across the globe. Our goal is to educate and spread awareness amongst women about our pain-less, non-touch, radiation-free clinically approved screening services. We’re looking forward to working with Healthspring to benefit patients in urban and semi-urban areas.”